The Food and Drug Administration warned in June 2005 that the use of antidepressants such as Zoloft can increase the risk of suicidal behavior in adults. The agency’s warning about Zoloft and other antidepressants came after several recent studies suggested an increased suicide risk among patients taking the drugs.
The FDA says that it will conduct a complete review of available data on the link between suicide and antidepressants in order to determine the health risks posed by the drug. The FDA has requested that the manufacturers of these drugs provide the agency with all available data from clinical trials regarding the link between suicide and antidepressants.
In a warning letter, the FDA advised that patients who are being treated with antidepressants like Zoloft should be monitored for signs of suicidal thinking or behavior. Patients who display any signs of these behaviors should be taken to a health care professional for evaluation.